Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-014594
Filing Date
2011-03-14
Accepted
2011-03-14 16:21:53
Documents
6
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v214527_10k.htm 10-K 1501282
2 v214527_ex23-1.htm EX-23.1 2964
3 v214527_ex31-1.htm EX-31.1 9715
4 v214527_ex31-2.htm EX-31.2 9712
5 v214527_ex32-1.htm EX-32.1 5383
6 v214527_ex32-2.htm EX-32.2 5430
  Complete submission text file 0001144204-11-014594.txt   1535589
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34058 | Film No.: 11685751
SIC: 2834 Pharmaceutical Preparations